(Jerusalem Post) Maayan Hoffman - The U.S. Patent Office on Thursday issued a patent to Haifa-based Pluristem Therapeutics Inc. which uses mesenchymal stem cells in skeletal muscle regeneration after muscle injury. The patent has already been granted in Europe, Hong Kong and Israel. Previous clinical studies showed a 300% improvement in muscle volume and a 500% boost in muscle force six months after surgery.
2017-12-01 00:00:00Full ArticleBACK Visit the Daily Alert Archive